Avid Hemp Announces Research-Support Initiative
FOR IMMEDIATE RELEASE
TAMPA, FL, [March 8, 2019] – Avid Hemp, one of the cannabidiol (CBD) industry’s most established and respected companies, is proud to announce its Avid Health Initiative. The program sends 5% of Avid Hemp’s monthly online sales to organizations doing vital research in the areas close to the hearts of Avid Hemp’s customers, with a focus on cancer and childhood epilepsy.
CBD has long been recognized as a remarkably effective treatment for the symptoms of childhood epilepsy. For years, it was difficult in most jurisdictions for parents to arrange purchase and delivery of this lifechanging compound, and those were exactly the years when Avid Hemp developed its reputation for nimble, responsive provision of premium CBD products. The FDA recently approved the first CBD-based epilepsy medication, and with more research, even more promising therapies are within reach.
Recent research suggests that CBD can dramatically slow the growth of cancer cells, or even destroy them, in controlled laboratory settings. Far more work remains to be done, as the American Cancer Society itself agrees, but with legal restrictions around CBD research beginning to relax, the prospects have never been brighter for a full exploration of CBD’s cancer-fighting properties.
This is the right time for full and open research on CBD, and Avid Hemp is the right company to help that research along.
“We’ve wanted to do something like this for a long time,” notes Avid Hemp co-founder Jesse Myers. “So many customers have thanked us for helping their children’s epilepsy symptoms, or that they’ve gotten relief from our products that they hadn’t found anywhere else. Our business is strong, and a remarkable percentage of our sales come from repeat customers. Legal restrictions on CBD research are being relaxed, and good news keeps coming to us from continuing research, so this was the right time to invest some of our success in research efforts that bridge our work and that of the mainstream medical community.”
Avid Hemp has achieved its status in the CBD marketplace by insisting on a remarkable degree of quality control. It starts with the highest-quality strains of hemp, grown organically by farmers in Florida and Colorado with whom Avid Hemp has longstanding relationships. Avid Hemp subjects samples from every batch of CBD to rigorous third-party laboratory testing. The company’s new facilities will bring CBD extraction entirely in-house starting in 2020.
This approach produces extraordinary consistency across Avid Hemp’s entire product line. Consistency is vital to the many customers who credit Avid Hemp with helping them end their addictions to opiates and nicotine, and to sufferers of longer-term conditions like epilepsy and cancer. Avid Hemp’s customers know that they’ll be getting the same highly effective, organic, all-natural remedies each time they order, and Avid Hemp knows that with every shipment it is improving the lives of its customers and, one bit of relief at a time, helping the communities in which they live.
Plenty of fly-by-night companies are looking to make a quick buck on CBD. Avid Hemp, though, is looking to make a difference. To learn more about Avid Hemp’s role in promoting CBD research, or about its approach to creating premium CBD products, please contact us at email@example.com or 1-877-957-0774.
Avid Hemp has one goal: to give its customers top-quality CBD products that actually work. Founded in 2017, the company distributes a wide range of premium CBD items worldwide, both directly and through its affiliate program.